Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma

K. Wang, Y. Chen, S. Liu, Suimin Qiu, S. Gao, X. Huang, J. Zhang, X. Peng, W. Qiani, Jian Ying Zhang

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In order to understand the immunogenicity of a tumor-associated antigen (TAA), Ras family small GTP binding protein (Ra1A) in hepatocellular carcinoma (HCC), autoantibody responses to RalA were evaluated by enzyme-linked immunosorbent assay (ELISA), Western blotting and indirect immunofluorescence assay in sera from patients with HCC and sera from normal individuals. Immunohistochemistry (IHC) study with tissue array slides was also preformed to analyze protein expression profiles of RalA in HCC and control tissues. This study demonstrated that RalA had a relative higher frequency of autoantibody response in HCC (20.1%) compared to liver cirrhosis (3.3%), chronic hepatitis (0%), and normal individuals sera (0%). RalA also showed a stepwise increased expression from normal liver tissues (26.7%), liver cirrhosis tissues (45.0%) to HCC tissues (63.3%). Sensitivity and specificity of anti-RalA antibody in detection of HCC was 20.1% and 99.3%, respectively. The data suggested that RalA might contribute to liver malignant transformation, and could be used as a potential tumor marker in HCC detection.

Original languageEnglish (US)
Pages (from-to)735-743
Number of pages9
JournalInternational Journal of Immunopathology and Pharmacology
Volume22
Issue number3
StatePublished - Jul 2009

Fingerprint

Hepatocellular Carcinoma
Liver Cirrhosis
Autoantibodies
Serum
Liver
Neoplasm Antigens
Chronic Hepatitis
Indirect Fluorescent Antibody Technique
Tumor Biomarkers
GTP-Binding Proteins
Anti-Idiotypic Antibodies
Western Blotting
Enzyme-Linked Immunosorbent Assay
Immunohistochemistry
Sensitivity and Specificity
Proteins

Keywords

  • Hepatocellular carcinoma
  • Immunoreactivity
  • Ra1A
  • Tissue expression
  • Tumor-associated antigen

ASJC Scopus subject areas

  • Pharmacology
  • Immunology
  • Immunology and Allergy

Cite this

Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma. / Wang, K.; Chen, Y.; Liu, S.; Qiu, Suimin; Gao, S.; Huang, X.; Zhang, J.; Peng, X.; Qiani, W.; Zhang, Jian Ying.

In: International Journal of Immunopathology and Pharmacology, Vol. 22, No. 3, 07.2009, p. 735-743.

Research output: Contribution to journalArticle

Wang, K, Chen, Y, Liu, S, Qiu, S, Gao, S, Huang, X, Zhang, J, Peng, X, Qiani, W & Zhang, JY 2009, 'Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma', International Journal of Immunopathology and Pharmacology, vol. 22, no. 3, pp. 735-743.
Wang, K. ; Chen, Y. ; Liu, S. ; Qiu, Suimin ; Gao, S. ; Huang, X. ; Zhang, J. ; Peng, X. ; Qiani, W. ; Zhang, Jian Ying. / Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma. In: International Journal of Immunopathology and Pharmacology. 2009 ; Vol. 22, No. 3. pp. 735-743.
@article{c390499f1323424fb98de39992fe3b17,
title = "Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma",
abstract = "In order to understand the immunogenicity of a tumor-associated antigen (TAA), Ras family small GTP binding protein (Ra1A) in hepatocellular carcinoma (HCC), autoantibody responses to RalA were evaluated by enzyme-linked immunosorbent assay (ELISA), Western blotting and indirect immunofluorescence assay in sera from patients with HCC and sera from normal individuals. Immunohistochemistry (IHC) study with tissue array slides was also preformed to analyze protein expression profiles of RalA in HCC and control tissues. This study demonstrated that RalA had a relative higher frequency of autoantibody response in HCC (20.1{\%}) compared to liver cirrhosis (3.3{\%}), chronic hepatitis (0{\%}), and normal individuals sera (0{\%}). RalA also showed a stepwise increased expression from normal liver tissues (26.7{\%}), liver cirrhosis tissues (45.0{\%}) to HCC tissues (63.3{\%}). Sensitivity and specificity of anti-RalA antibody in detection of HCC was 20.1{\%} and 99.3{\%}, respectively. The data suggested that RalA might contribute to liver malignant transformation, and could be used as a potential tumor marker in HCC detection.",
keywords = "Hepatocellular carcinoma, Immunoreactivity, Ra1A, Tissue expression, Tumor-associated antigen",
author = "K. Wang and Y. Chen and S. Liu and Suimin Qiu and S. Gao and X. Huang and J. Zhang and X. Peng and W. Qiani and Zhang, {Jian Ying}",
year = "2009",
month = "7",
language = "English (US)",
volume = "22",
pages = "735--743",
journal = "International Journal of Immunopathology and Pharmacology",
issn = "0394-6320",
publisher = "Biomedical Research Press s.a.s.",
number = "3",

}

TY - JOUR

T1 - Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma

AU - Wang, K.

AU - Chen, Y.

AU - Liu, S.

AU - Qiu, Suimin

AU - Gao, S.

AU - Huang, X.

AU - Zhang, J.

AU - Peng, X.

AU - Qiani, W.

AU - Zhang, Jian Ying

PY - 2009/7

Y1 - 2009/7

N2 - In order to understand the immunogenicity of a tumor-associated antigen (TAA), Ras family small GTP binding protein (Ra1A) in hepatocellular carcinoma (HCC), autoantibody responses to RalA were evaluated by enzyme-linked immunosorbent assay (ELISA), Western blotting and indirect immunofluorescence assay in sera from patients with HCC and sera from normal individuals. Immunohistochemistry (IHC) study with tissue array slides was also preformed to analyze protein expression profiles of RalA in HCC and control tissues. This study demonstrated that RalA had a relative higher frequency of autoantibody response in HCC (20.1%) compared to liver cirrhosis (3.3%), chronic hepatitis (0%), and normal individuals sera (0%). RalA also showed a stepwise increased expression from normal liver tissues (26.7%), liver cirrhosis tissues (45.0%) to HCC tissues (63.3%). Sensitivity and specificity of anti-RalA antibody in detection of HCC was 20.1% and 99.3%, respectively. The data suggested that RalA might contribute to liver malignant transformation, and could be used as a potential tumor marker in HCC detection.

AB - In order to understand the immunogenicity of a tumor-associated antigen (TAA), Ras family small GTP binding protein (Ra1A) in hepatocellular carcinoma (HCC), autoantibody responses to RalA were evaluated by enzyme-linked immunosorbent assay (ELISA), Western blotting and indirect immunofluorescence assay in sera from patients with HCC and sera from normal individuals. Immunohistochemistry (IHC) study with tissue array slides was also preformed to analyze protein expression profiles of RalA in HCC and control tissues. This study demonstrated that RalA had a relative higher frequency of autoantibody response in HCC (20.1%) compared to liver cirrhosis (3.3%), chronic hepatitis (0%), and normal individuals sera (0%). RalA also showed a stepwise increased expression from normal liver tissues (26.7%), liver cirrhosis tissues (45.0%) to HCC tissues (63.3%). Sensitivity and specificity of anti-RalA antibody in detection of HCC was 20.1% and 99.3%, respectively. The data suggested that RalA might contribute to liver malignant transformation, and could be used as a potential tumor marker in HCC detection.

KW - Hepatocellular carcinoma

KW - Immunoreactivity

KW - Ra1A

KW - Tissue expression

KW - Tumor-associated antigen

UR - http://www.scopus.com/inward/record.url?scp=70350556969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350556969&partnerID=8YFLogxK

M3 - Article

C2 - 19822090

AN - SCOPUS:70350556969

VL - 22

SP - 735

EP - 743

JO - International Journal of Immunopathology and Pharmacology

JF - International Journal of Immunopathology and Pharmacology

SN - 0394-6320

IS - 3

ER -